The latest closing stock price for Grace Therapeutics as of March 28, 2025 is 2.32.
An investor who bought $1,000 worth of Grace Therapeutics stock at the IPO in 2012 would have $-996 today, roughly -1 times their original investment - a -34.61% compound annual growth rate over 13 years.
The all-time high Grace Therapeutics stock closing price was 1953.60 on August 05, 2013.
The Grace Therapeutics 52-week high stock price is 4.96, which is 113.8% above the current share price.
The Grace Therapeutics 52-week low stock price is 2.07, which is 10.8% below the current share price.
The average Grace Therapeutics stock price for the last 52 weeks is 3.07.
An investor who bought $1,000 worth of Grace Therapeutics stock at the IPO in 2012 would have $-996 today, roughly -1 times their original investment - a -34.61% compound annual growth rate over 13 years.
The all-time high Grace Therapeutics stock closing price was 1953.60 on August 05, 2013.
The Grace Therapeutics 52-week high stock price is 4.96, which is 113.8% above the current share price.
The Grace Therapeutics 52-week low stock price is 2.07, which is 10.8% below the current share price.
The average Grace Therapeutics stock price for the last 52 weeks is 3.07.